Explore the words cloud of the LIFEOMEGA project. It provides you a very rough idea of what is the project "LIFEOMEGA" about.
The following table provides information about the project.
SOLUTEX GC SL
|Coordinator Country||Spain [ES]|
|Total cost||2˙445˙781 €|
|EC max contribution||1˙712˙046 € (70%)|
1. H2020-EU.3.2.4. (Sustainable and competitive bio-based industries and supporting the development of a European bioeconomy)
2. H2020-EU.3.2.1. (Sustainable agriculture and forestry)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.2.2. (Sustainable and competitive agri-food sector for a safe and healthy diet)
|Duration (year-month-day)||from 2017-03-01 to 2019-02-28|
Take a look of project's partnership.
|1||SOLUTEX GC SL||ES (ALCOBENDAS MADRID)||coordinator||1˙712˙046.00|
The objective of the project is the industrial and market development of a high concentrated Omega3 EPA nutritional product addressed to improve the health of cancer patients.
LIFEOMEGA-cancer can be considered one chemotherapy essential nutrient co-adjuvant by overcoming:
1. The deficit of necessary level essential Omega3 EPA fatty acid by one efficient concentration and daily dosage (min 2.2 g EPA per day) 2. On a convenient way for the patient overcoming unpleasant fishy taste and with one unique delivery form
The product is protected by IP and constitutes a unique product and solution, not present in the market. Moreover, it is flavourized, and being an emulsion, it can be conveniently delivered in other liquids. These features make the product a complete breakthrough Medical Food in the essential nutrition market, both in Europe and in the USA.
Cancer patients receiving chemotherapy will be highly benefitted with LIFEOMEGA product; they can have their treatments (as cancer chemo/radiotherapy treatments) outcomes improved, their length of hospital stay reduced, and their quality of life during and after treatment increased. The high convenience allows the consumption of fewer dosages to achieve the targeted Omega3 levels.
LIFEOMEGA has a great potential, as it is estimated that cancer patients recieving chemotherapy unfortunately won't be less than 1 millon / year during the next 11 years, in USA, Spain, France, Germany, UK and Italy.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LIFEOMEGA" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "LIFEOMEGA" are provided by the European Opendata Portal: CORDIS opendata.
An Innovative Integrated Field Sensor system providing a precise farming tool to reduce productioncosts and water wastage.Read More
ANTIBIOTICS CONTROL FOR ALLRead More
An innovative bio-based platform for the cost-competitive production of L-fucose, a building block for Human Milk Oligosaccharides (HMOs).Read More